Myeloid dendritic cells (mDC) vaccinations (Radboud University)

N/A

Report date: 2024/03/07 13:13:11

Base Information

Drug NameMyeloid dendritic cells (mDC) vaccinations (Radboud University)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsProstatic NeoplasmsInfluenza B virus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRadboud University Nijmegen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRadboud University Medical Center
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsInfluenza B virus infection

Other Information

ATC CodeN/A
Related LinksN/A